Reporting owner · CIK 0001724169

VanHimbergen Robert M

Visual SEC Form 4 history across 2 companies, 11 transactions and 5 filings.

ECEVP and CFOElanco Animal Health Inc
Open-market mix
Latest filingSep 09, 2026, 09:10 PM
Filings5Form 4 records
Buying$65.7K1 purchases
Selling$00 sales
Net value$65.7KBuys minus sells
Companies26 securities
Most recentSep 04, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Dec 23Dec 241Feb 25Feb 26Sep 26

Net value flow

Buys minus sells

Dec 23
$0
Dec 24
$0
Feb 25
$65.7K
Feb 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$65.7K
Median P/S size$65.7K
Direct11
Indirect0
Sep 04, 2026grant

Filing-only signals

Deterministic matches in this insider's history

Cluster Buypattern1Derivative Transactionfiling-context9Direct Ownershipfiling-context10Large Holdings Increaseholdings1

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at Hillenbrand, Inc. on Feb 10, 2025 valued at $65,698.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

ELANElanco Animal Health Inc2 transactions · latest Sep 09, 2026, 09:10 PMHIHillenbrand, Inc.9 transactions · latest Feb 10, 2025, 09:10 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ELANVanHimbergen Robert M
EC
grant8$19.7kA
Derivative Transaction Direct Ownership
0.0%09/0909/04
ELANVanHimbergen Robert M
EC
grant8$19.0kA
Derivative Transaction Direct Ownership Large Holdings Increase
−15.2%02/1002/06
HIVanHimbergen Robert M
SVCFO
buy2.00k$6.56MP
Cluster Buy Direct Ownership
—02/10/202502/10/2025
HIVanHimbergen Robert M
SVCFO
grant106$0A
Derivative Transaction Direct Ownership
—01/03/202512/31/2024
HIVanHimbergen Robert M
SVCFO
grant57$0A
Derivative Transaction Direct Ownership
—01/03/202512/31/2024
HIVanHimbergen Robert M
SVCFO
grant20$0A
Derivative Transaction Direct Ownership
—01/03/202512/31/2024
HIVanHimbergen Robert M
SVCFO
grant165$0A
Derivative Transaction Direct Ownership
—01/03/202512/31/2024
HIVanHimbergen Robert M
SVCFO
grant53$0A
Derivative Transaction Direct Ownership
—01/03/202412/29/2023
HIVanHimbergen Robert M
SVCFO
grant25$0A
Derivative Transaction Direct Ownership
—01/03/202412/29/2023
HIVanHimbergen Robert M
SVCFO
grant13$0A
Derivative Transaction Direct Ownership
—01/03/202412/29/2023

VanHimbergen Robert M Insider Activity FAQ

SEC Form 4 context

Who is VanHimbergen Robert M?

VanHimbergen Robert M is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001724169.

Which companies has VanHimbergen Robert M reported transactions for?

Elanco Animal Health Inc, Hillenbrand, Inc.

When was VanHimbergen Robert M's latest insider buy?

buy at Hillenbrand, Inc. on Feb 10, 2025 valued at $65,698.

When was VanHimbergen Robert M's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.